Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Telavive
Pelles Sharon
23 tahun pengalaman
Klinik telah bersertifikat :
| Israel | Turki | Austria | |
| Terapi SIRT | dari $24,500 | dari $24,000 | dari $17,000 |
Bookimed tidak menambah biaya tambahan dalam harga Terapi SIRT. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik untuk Terapi SIRT Anda saat tiba.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam Terapi SIRT dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan Terapi SIRT Anda.
Dr. Pelles Sharon berspesialisasi dalam terapi SIRT di Sourasky Medical Center, membawa keahlian luas dalam perawatan kanker tingkat lanjut.
Prof. Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center – salah satu departemen onkologi terkemuka di Israel.
Dr. Amit Tirosh is the Head of the Neuroendocrine Tumors (NET) Service at Sheba Medical Center. He is an international authority on von Hippel–Lindau (VHL) disease and hereditary tumor syndromes. Dr. Tirosh contributed to global clinical guidelines for VHL management. He also leads the Endocrine Oncology Bioinformatics Lab at Sheba.
Dr. Almog Ben Yaacov is a senior surgical oncologist at Sheba Medical Center. He has performed over 200 HIPEC procedures for complex abdominal cancers. He focuses on treating gastric cancer, sarcoma, and colorectal malignancies. Dr. Ben Yaacov holds board certifications in both General Surgery and Surgical Oncology.
SIRT therapy, or Y90 radioembolization, is a minimally invasive treatment for inoperable liver tumors. In Israel, interventional radiologists inject radioactive Yttrium-90 microspheres into the liver artery. These beads lodge in tumor vessels, delivering targeted beta radiation while preserving healthy surrounding tissue.
Bookimed Expert Insight: Israeli oncology centers like Sourasky manage high patient volumes, seeing 40,000 cancer patients annually. This massive throughput allows specialists like Dr. Pelles Sharon to refine delivery protocols. High volumes often correlate with better outcomes in complex interventional radiology procedures.
Patient Consensus: Patients often refer to this treatment specifically as Y90 radioembolization. Many emphasize that this is internal radiation, which differs significantly from external beam therapies like SBRT.
SIRT treatment is safe and fully approved in Israel for treating inoperable liver tumors. The Israeli Ministry of Health, Joint Commission International (JCI), and FDA approve SIR-Spheres for clinical use. Leading oncology centers like Sourasky Medical Center (Ichilov) utilize this minimally invasive radioactive bead therapy safely.
Bookimed Expert Insight: While SIRT protocol for liver cancer is established, patients must distinguish it from SIRT-6 protein research. Israeli scientists are leaders in SIRT-6 age-reversing studies, but these are currently pre-clinical. When booking, specify selective internal radiation therapy to ensure you are reaching clinical oncology departments instead of research labs.
Patient Consensus: Patients are often advised to double-check if their specific case qualifies for SIRT versus other approved options like CAR-T therapy. High satisfaction is reported when coordinating with hospital international departments to verify the availability of certified radioactive isotopes.
SIRT therapy in Israel is a minimally invasive procedure delivering radioactive Yttrium-90 microspheres directly to liver tumors. Performed by specialists like Dr. Pelles Sharon at Sourasky Medical Center, it targets cancer cells with high-dose radiation while sparing healthy tissue and typically requires one week of recovery.
Bookimed Expert Insight: Israeli oncology centers like Sourasky manage massive volumes, seeing 40,000 cancer patients annually. This high frequency means teams are exceptionally fast at identifying the exact vascular map needed for bead delivery. Their expertise often reduces the time patients spend under specialized imaging, which minimizes overall radiation exposure during the mapping phase.
Patient Consensus: Many find the fatigue after SIRT more intense than expected, often lasting several weeks. While liver pain can linger for months, it is generally manageable with standard medication and rest.
SIRT therapy is available at major Israeli oncology centers including Sourasky Medical Center, Sheba Medical Center, and Assuta Medical Center. These JCI-accredited facilities provide radioembolization for liver cancer using multidisciplinary teams of interventional radiologists and nuclear medicine specialists in Tel Aviv and Ramat Gan.
Bookimed Expert Insight: While many patients search for SIRT, Israeli specialists like Dr. Beni Boursi at Sheba Medical Center often evaluate if NanoKnife or microwave ablation might be more effective. Choosing a hospital that offers all three technologies ensures your treatment is selected based on clinical need rather than equipment availability.
Patient Consensus: Patients are often advised to request radioembolization by name when contacting clinics. General sentiment highlights that major institutions have high radiotherapy capacity, often performing other advanced treatments like CAR-T alongside SIRT.